Telo Genomics Corp.

C$0.04As of Sun 8 Nov 2026, 12:00 UTC
TSXV:TELOHealthcare
Country Canada
PE (Fwd) •••
TSR 10Y CAGR (34.45%)
Div yield —
ROE —
Diagnostics & Research
Beta (5Y) 0.04
PE TTM —
TSR TTM (18.18%)
Mkt cap C$4.519M
ROIC (727.79%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.0434
(3.45%)
(42.74%)
Sell 1|8|8|9|12
2Q26
3Q26
4Q26
1Q27
Earnings per share$
—
—
—
—
24.56%
10.11%
12.10%
24.09%
Revenue$M
0.500
0.516
0.516
0.509
11.12%
11.41%
7.08%
0.12%
Peers (US$3.199M)
Cap (US$)
PE
3.271M
0.371x
Capital
TTM
5Y
10Y
Leveragex
2.008
(0.027)
(0.024)
EBIT/Intx
0.388
1.116
1.007
Own earn%
(28.07)
(65.98)
(77.30)
Sh yield%
29.07
18.52
19.73
Owners
Insiders/Inst%
13.97
87.61
Short interest%
2.21
SBC / revenue%
5.41
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
12–17
$1 testx
0.1
Incr. ROIC%
16